Managing sudden death risk in young patients with hypertrophic cardiomyopathy (HCM) is challenging for its lifetime implications from both action and inaction, and this decision often relies on shared decision-making by families and clinicians. Thus, the development of risk assessment tools to guide parents and health care professionals are welcome additions to the scientific literature. The study by Norrish and coworkers1 in this issue of JAMA Cardiology is an initial step in creating a risk tool, and as a first step, the editors hope this work will stimulate further discussion and investigation to better refine this tool.
Bonow RO, McNally EM. Risk Prediction Model in Children With Hypertrophic Cardiomyopathy: A Work in Progress. JAMA Cardiol. Published online August 14, 2019. doi:10.1001/jamacardio.2019.2945
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: